Agios Pharmaceuticals Inc, based in San Mateo, CA, is a pioneering leader in cellular metabolism, dedicated to developing groundbreaking therapies for patients with rare diseases. With a focus on hemolytic and acquired anemias, Agios aims to establish a strong portfolio of therapeutic candidates that have the potential to provide disease-modifying and long-term effects for patients with unmet needs.
At Agios, patient needs and collaboration are at the forefront of their work, ensuring that the therapies they develop and the support programs they provide address the specific needs of the patients they represent. With a commitment to maintaining a supportive and flexible work environment, Agios fosters a culture that empowers their team to push the boundaries of science and make a significant impact in the lives of people with rare diseases.
Generated from the website